ALGIAX PHARMACEUTICALS GMBH has a total of 26 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NEUROMOLECULAR INC, CHEMIOSYNTEX SRL and NEUROGESX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | United States | 3 | |
#6 | Australia | 1 | |
#7 | Hungary | 1 | |
#8 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hasse Birgit | 26 |
#2 | Koopmans Guido | 26 |
#3 | Muellner Stefan | 2 |
#4 | Müllner Stefan | 1 |
Publication | Filing date | Title |
---|---|---|
CA2942446A1 | Treatment of cognitive disorders | |
AU2015233686A1 | 2-Cyano-3-cyclopropyl-3-hydroxy-N-aryl-thioacrylamide derivatives | |
WO2013156231A1 | Use of imidazotriazinones in neuropathic pain | |
WO2013156232A1 | Use of benzofuranylsulfonates in neuropathic pain | |
WO2012123406A1 | Novel use of imidazotriazinones | |
WO2012123353A1 | Novel use of benzofuranylsulfonates | |
EP2632451A2 | Use of malononitrilamides in neuropathic pain | |
EP2608782A1 | Novel use of leflunomide and malononitrilamides |